Human chimerism levels ranged from 59.7% to 0.0175% hCD45+ cells after 6 months, with secondary transplantation of 1 × 105 CD34+ cells without MSCs maintaining 53.33% chimerism, demonstrating the long-term self-renewal capacity of MDS-initiating cells. The gene discussed is CD34; the disease is myelodysplastic syndrome.